UB Paderborn / Katalog / Suche / in CDI

1 – 14 von 14

Sortiert nach

Zoledronic Acid Prevents Cancer Treatment–Induced Bone Loss in Premenopausal Women Receiving Adjuvant Endocrine Therapy for Hormone-Responsive Breast Cancer: A Report From the Austrian Breast and Colorectal Cancer Study Group

Journal of clinical oncology, 2007-03, Vol.25 (7), p.820-828

2007

Volltextzugriff (PDF)

San Antonio 2019: interesting topics for daily clinical practice in breast cancer

Memo - Magazine of European medical oncology, 2020-09, Vol.13 (3), p.349-352

Galid, Arik

2020

Volltextzugriff (PDF)

Pathologic Complete Response With Six Compared With Three Cycles of Neoadjuvant Epirubicin Plus Docetaxel and Granulocyte Colony-Stimulating Factor in Operable Breast Cancer: Results of ABCSG-14

Journal of clinical oncology, 2007-05, Vol.25 (15), p.2012-2018

2007

Volltextzugriff (PDF)

Impact of pretreatment thrombocytosis on survival in primary breast cancer

Thrombosis and haemostasis, 2003-06, Vol.89 (6), p.1098

2003

Volltextzugriff (PDF)

First exercise group for Turkish breast cancer patients in Vienna - a pilot project to include Turkish migrants

Disability and rehabilitation, 2020-01, Vol.42 (1), p.20-25

2020

Volltextzugriff (PDF)

Current concepts and future directions in neoadjuvant chemotherapy of breast cancer

Memo - Magazine of European medical oncology, 2018, Vol.11 (3), p.199-203

2018

Volltextzugriff (PDF)

Activity of T-DM1 in Her2-positive breast cancer brain metastases

Clinical & experimental metastasis, 2015-10, Vol.32 (7), p.729-737

2015

Volltextzugriff (PDF)

An update on immunotherapy in breast cancer

Memo - Magazine of European medical oncology, 2019-03, Vol.12 (1), p.63-66

2019

Volltextzugriff (PDF)

REACHAUT: First-line (1L) ribociclib (RIB) + endocrine therapy (ET) in HR+, HER2- metastatic breast cancer (MBC) in the real-world setting

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e12527-e12527

2019

Volltextzugriff (PDF)

Axillary lymph node metastases in patients with breast carcinomas: assessment with nonenhanced versus uspio-enhanced MR imaging

Radiology, 2006-11, Vol.241 (2), p.367

2006

Volltextzugriff (PDF)

Abstract P6-16-10: Activity of T-DM1 in HER2-positive breast cancer brain metastases

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P6-P6-16-10

2015

Volltextzugriff (PDF)

Prophylactic long-acting granulocyte-colony stimulating factors (G-CSF) in gynecologic malignancies: an oncologic expert statement

Wiener medizinische Wochenschrift, 2015-10, Vol.165 (19-20), p.387-394

2015

Volltextzugriff (PDF)

Polymorphisms of the endothelial nitric oxide synthase gene in women with vulvar cancer

Gynecologic oncology, 2004-06, Vol.93 (3), p.686-690

2004

Volltextzugriff (PDF)

Pharmacological modulation of local feedback mechanisms as a therapeutic approach in breast cancer treatment

Drugs of today (Barcelona, Spain : 1998), 2003-12, Vol.39 (12), p.917-926

2003

Volltextzugriff (PDF)

1 – 14 von 14

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(13)
Mit Volltextzugriff
(11)

Publikationsform

Artikel
(14)

Sprache

Englisch
(14)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Zoledronic Acid Prevents Cancer Treatment–Induced Bone Loss in Premenopausal Women Receiving Adjuvant Endocrine Therapy for Hormone-Responsive Breast Cancer: A Report From the Austrian Breast and Colorectal Cancer Study Group

San Antonio 2019: interesting topics for daily clinical practice in breast cancer

Pathologic Complete Response With Six Compared With Three Cycles of Neoadjuvant Epirubicin Plus Docetaxel and Granulocyte Colony-Stimulating Factor in Operable Breast Cancer: Results of ABCSG-14

Impact of pretreatment thrombocytosis on survival in primary breast cancer

First exercise group for Turkish breast cancer patients in Vienna - a pilot project to include Turkish migrants

Current concepts and future directions in neoadjuvant chemotherapy of breast cancer

Activity of T-DM1 in Her2-positive breast cancer brain metastases

An update on immunotherapy in breast cancer

REACHAUT: First-line (1L) ribociclib (RIB) + endocrine therapy (ET) in HR+, HER2- metastatic breast cancer (MBC) in the real-world setting

Axillary lymph node metastases in patients with breast carcinomas: assessment with nonenhanced versus uspio-enhanced MR imaging

Abstract P6-16-10: Activity of T-DM1 in HER2-positive breast cancer brain metastases

Prophylactic long-acting granulocyte-colony stimulating factors (G-CSF) in gynecologic malignancies: an oncologic expert statement

Polymorphisms of the endothelial nitric oxide synthase gene in women with vulvar cancer

Pharmacological modulation of local feedback mechanisms as a therapeutic approach in breast cancer treatment

Suchergebnisse filtern